<Disease><Name>PHENYLKETONURIA, FETAL EFFECTS FROM MATERNAL (MPKU)</Name><Synonym /><OMIM><Number>261600</Number><URL>http://omim.org/entry/261600</URL></OMIM><Orphanet><Number>2209</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=2209</URL></Orphanet><Protein><Number /><URL /></Protein><ExPASy><Number>1.14.16.1</Number><URL>http://enzyme.expasy.org/EC/1.14.16.1</URL></ExPASy><Gene>13q23.2Detail information to gene locus by the National Center for Biotechnology Information NCBI:

Phenylalanine hydroxylase
</Gene><ICD>E70.1</ICD><Summary>Definition: Elevated Phenylalanine in a mother with phenylketonuria causes damage to the fetus during pregnancy. Severity of intrauterine damage is dependent from the concentration of phenylalanine in the mothers blood Underlying defect: Phenylketonuria is caused mainly by a deficiency of phenylalanine hydroxylase in the liver and causes high phenylalanine in body fluids and excretion of organic acids in urine Diagnosis: Diagnosis is usually made in the newborn by the neonatal screening program (Guthrie test). Amino acid measurement in dried blood (filter paper) or serum/plasma (200 &#180;+&#162;l) is the method of choice. Undiagnosed untreated patients may also be detected by analyzing organic acids in urine. Tetrahydrobiopterin (BH4) deficiency should be excluded by a BH4 loading test measuring blood phenylalanine before and after load and measurement of pterines in urine. Mutational analysis of the PAH-gene confirms the diagnosis. Knowledge of mutations is of help in the management of dietary treatment and in the evaluation of BH-sensitivity in mild phenylketonuria.</Summary><Symptoms><symtomp><id>2153</id><symptom>aorta, coarction</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1720</id><symptom>congenital heart defect</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1782</id><symptom>epicanthus or medial eyelid fold</symptom><category>EYES</category></symtomp><symtomp><id>2148</id><symptom>exposure to phenylalanine during gestation</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3863</id><symptom>low birthweight (small for gestational age)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1717</id><symptom>no clinical symptoms (probably) / no clinical  significance</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1809</id><symptom>short philtrum</symptom><category>HEAD</category></symtomp><symtomp><id>1700</id><symptom>small for gestational age (SGA), intrauterine growth retardation (IUGR)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2152</id><symptom>tetralogy of fallot</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2150</id><symptom>ventricular septal defect</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1652</id><name>Phenylalanine</name><specimen>urine</specimen><value /><min>3.50</min><max>11.20</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1781</id><name>Phenylalanine</name><specimen>urine</specimen><value /><min>0.00</min><max>120.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1961</id><name>Phenylalanine</name><specimen>blood</specimen><value /><min>0.00</min><max>120.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1962</id><name>Phenylalanine</name><specimen>plasma</specimen><value /><min>34.00</min><max>86.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1919</id><name>Phenylalanine</name><specimen>urine</specimen><value /><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>502</id><name>no specific laboratory findings (P, S, U ,CSF)</name><specimen /><value /><min>    </min><max>    </max><unit /><age>no data</age><method /><comment /></metabolite><metabolite><id>1548</id><name>Phenylalanine</name><specimen>urine</specimen><value /><min>5.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>156</id><name>Phenylalanine</name><specimen>urine</specimen><value /><min>4.00</min><max>32.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>871</id><name>Phenylalanine</name><specimen>urine</specimen><value /><min>6.00</min><max>31.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1513</id><name>Phenylalanine</name><specimen>urine</specimen><value /><min>7.00</min><max>28.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>52</id><name>Phenylalanine</name><specimen>plasma</specimen><value /><min>21.00</min><max>137.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>930</id><name>Phenylalanine</name><specimen>cerebrospinal fluid</specimen><value /><min>0.00</min><max>20.00</max><unit>&#956;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1057</id><name>Phenylalanine</name><specimen>plasma</specimen><value /><min>35.00</min><max>85.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1294</id><name>Phenylalanine</name><specimen>plasma</specimen><value /><min>26.00</min><max>85.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1295</id><name>Phenylalanine</name><specimen>plasma</specimen><value /><min>26.00</min><max>98.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite></Metabolites><Literatures><literature><id>8240</id><title>Management of Women With Phenylalanine Hydroxylase Deficiency (Phenylketonuria): ACOG Committee Opinion, Number 802</title><author>No authors listed</author><journal>Obstet Gynecol</journal><year>2020</year><book /><volume>135</volume><number>4</number><pages>e167-170</pages><co_aut /></literature><literature><id>8241</id><title>Management of Women With Phenylalanine Hydroxylase Deficiency (Phenylketonuria): ACOG Committee Opinion Summary, Number 802</title><author>No authors listed</author><journal>Obstet Gynecol</journal><year>2020</year><book /><volume>135</volume><number>4</number><pages>987-988</pages><co_aut /></literature><literature><id>6376</id><title>Phenylalanine and tyrosine measurements across gestation by tandem mass spectrometer on dried blood spot cards from normal preg</title><author>McBride KL,</author><journal>Genet Med</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6380</id><title>Successful control of maternal phenylketonuria by tetrahydrobiopterin</title><author>Sakamoto O,</author><journal>Pediatr Int</journal><year>2018</year><book /><volume>60</volume><number>10</number><pages>985-986</pages><co_aut>et al.</co_aut></literature><literature><id>6381</id><title>50 Years Ago in The Journal of Pediatrics: Maternal Phenylketonuria: Implications for Growth and Development</title><author>Ross LF,</author><journal>J Pediatr</journal><year>2018</year><book /><volume>201</volume><number>0</number><pages>121</pages><co_aut>Paul DB</co_aut></literature><literature><id>6382</id><title>50 Years Ago in The Journal of Pediatrics: Phenylketonuria and Scleroderma</title><author>Hashkes PJ</author><journal>J Pediatr</journal><year>2018</year><book /><volume>201</volume><number>0</number><pages>2044</pages><co_aut /></literature><literature><id>6383</id><title>50 Years Ago in The Journal of Pediatrics: Variability in the Manifestations of Phenylketonuria/Transient Hyperphenylalaninemia</title><author>Ross LF;</author><journal>J Pediatr</journal><year>2018</year><book /><volume>195</volume><number>0</number><pages>65</pages><co_aut>Paul DB</co_aut></literature><literature><id>6384</id><title>50 Years Ago in The Journal of Pediatrics: Phenylketonuria: Evaluation of Therapy and Verification of Diagnosis</title><author>Saugstad OD</author><journal>J Pediatr</journal><year>2018</year><book /><volume>193</volume><number>0</number><pages>92</pages><co_aut /></literature><literature><id>3298</id><title>A GC/MS-based metabolomic approach for reliable diagnosis of phenylketonuria</title><author>Xiong X,</author><journal>Anal Bioanal Chem</journal><year>2015</year><book /><volume>407</volume><number>29</number><pages>8825-8833</pages><co_aut>et al.</co_aut></literature><literature><id>3299</id><title>Medical Problems in Obstetrics: Inherited Metabolic Disease</title><author>Murphy E</author><journal>Best Pract Res Clin Obstet Gynaecol</journal><year>2015</year><book /><volume>29</volume><number>5</number><pages>707-720</pages><co_aut /></literature><literature><id>3300</id><title>Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach</title><author>Aguiar A,</author><journal>Mol Genet Metab</journal><year>2015</year><book /><volume>115</volume><number>1</number><pages>17-22</pages><co_aut>et al.</co_aut></literature><literature><id>3301</id><title>The Kuvan(&#174;) Adult Maternal Paediatric European Registry (KAMPER) Multinational Observational Study: Baseline and 1-Year Data in Phenylketonuria Patients Responsive to Saprop</title><author>Trefz FK,</author><journal>JIMD Rep</journal><year>2015</year><book /><volume>23</volume><number>0</number><pages>35-43</pages><co_aut>et al.</co_aut></literature><literature><id>3302</id><title>Maternal Phenylketonuria: Long-term Outcomes in Offspring and Post-pregnancy Maternal Characteristics</title><author>Waisbren SE,</author><journal>JIMD Rep</journal><year>2015</year><book /><volume>21</volume><number>0</number><pages>23-33</pages><co_aut>et al.</co_aut></literature><literature><id>3297</id><title>Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases</title><author>Feillet F,</author><journal>J Inherit Metab Dis</journal><year>2014</year><book /><volume>37</volume><number>5</number><pages>753-762</pages><co_aut>et al.</co_aut></literature><literature><id>3305</id><title>Methylome repatterning in a mouse model of Maternal PKU Syndrome</title><author>Dobrowolski SF,</author><journal>Mol Genet Metab</journal><year>2014</year><book /><volume>113</volume><number>3</number><pages>194-199</pages><co_aut>et al.</co_aut></literature><literature><id>2780</id><title>Finding the fertile woman with phenylketonuria</title><author>Hanley WB.</author><journal>Eur J Obstet Gynecol Reprod Biol</journal><year>2008</year><book /><volume>137</volume><number>2</number><pages>131-135</pages><co_aut /></literature><literature><id>2158</id><title>Maternal phenylketonuria: report from the United Kingdom Registry 1978-97</title><author>Lee PJ</author><journal>Arch Dis Child</journal><year>2005</year><book /><volume>90</volume><number>2</number><pages>143-146</pages><co_aut>et al.</co_aut></literature><literature><id>2159</id><title>Maternal phenylketonuria: the importance of early control during pregnancy</title><author>Koch R</author><journal>Arch Dis Child</journal><year>2005</year><book /><volume>90</volume><number>2</number><pages>114-115</pages><co_aut /></literature><literature><id>2160</id><title>Maternal Phenylketonuria Collaborative Study (MPKUCS)--the outliers</title><author>Hanley WB</author><journal>J Inherit Metab Dis</journal><year>2004</year><book /><volume>27</volume><number>6</number><pages>711-723</pages><co_aut>et al.</co_aut></literature><literature><id>2161</id><title>Maternal phenylketonuria: the French survey</title><author>Feillet F</author><journal>Eur J Pediatr</journal><year>2004</year><book /><volume>163</volume><number>0</number><pages>540-546</pages><co_aut>et al.</co_aut></literature><literature><id>2162</id><title>Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria</title><author>Trefz FK</author><journal>Pediatrics</journal><year>2003</year><book /><volume>112</volume><number>0</number><pages>1466-1569</pages><co_aut>Blau N</co_aut></literature><literature><id>731</id><title>Maternal phenylketonuria collaborative study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequela</title><author>Rouse B</author><journal>Am J Med Genet</journal><year>1997</year><book /><volume>69</volume><number>0</number><pages>89-95</pages><co_aut>et al.</co_aut></literature><literature><id>628</id><title>Microcephaly and maternal phenylketonuria</title><author>Superti-Furga A</author><journal>Eur J Pediatr</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>992</pages><co_aut>Steinmann B, Duc G, Gitzelmann R</co_aut></literature><literature><id>629</id><title>[Pregnancy and the child of a mother with phenylketonuria]</title><author>Abadie V</author><journal>Arch Pediatr</journal><year>1996</year><book>french</book><volume>3</volume><number>0</number><pages>489-</pages><co_aut>et al.</co_aut></literature><literature><id>630</id><title>Maternal phenylketonuria: magnetic resonance imaging of the brain in offspring</title><author>Levy HL</author><journal>J Pediatr</journal><year>1996</year><book /><volume>128</volume><number>0</number><pages>770-775</pages><co_aut>Lobbregt D, Barnes PD, Poussaint TY</co_aut></literature><literature><id>115</id><title>The international collaborative study of maternal phenylketonuria: status report 1994</title><author>Koch R</author><journal>Acta Paediatr Scan</journal><year>1994</year><book /><volume>407</volume><number>0</number><pages>111-119</pages><co_aut>et al.</co_aut></literature><literature><id>207</id><title>Maternal mild hyperphenylalaninemia: an international survey of offspring outcome</title><author>Levy HL</author><journal>Lancet</journal><year>1994</year><book /><volume>344</volume><number>0</number><pages>1589-1594</pages><co_aut>et al.</co_aut></literature><literature><id>114</id><title>Maternal phenylketonuria and hyperphenylalaninemia: an international survey of the outcome of untreated and treated pregnancies&lt;</title><author>Lenke RR</author><journal>N Engl J Med</journal><year>1980</year><book /><volume>303</volume><number>0</number><pages>1202-1208</pages><co_aut>Levy HL</co_aut></literature></Literatures></Disease>